Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1988 Nov;34:2503–2508.

Transfusion Support of the Transplant Patient

Eric Nisbet-Brown
PMCID: PMC2219002  PMID: 21253122

Abstract

Organ transplant has become a much more common procedure in recent years. Data suggest that blood transfusions prior to transplant can affect allograph survival. The author discusses blood transfusion in kidney and liver transplantation.

Keywords: blood transfusions, organ transplant

Full text

PDF
2503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson C. B., Tyler J. D., Rodey G. E., Etheredge E. E., Anderman C. K., Flye M. W., Jendrisak M. D., Sicard G. A. Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions. Transplant Proc. 1987 Feb;19(1 Pt 2):1494–1497. [PubMed] [Google Scholar]
  2. Beveridge T. Clinical transplantation--overview. Prog Allergy. 1986;38:269–292. [PubMed] [Google Scholar]
  3. Bontempo F. A., Lewis J. H., Van Thiel D. H., Spero J. A., Ragni M. V., Butler P., Israel L., Starzl T. E. The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation. 1985 May;39(5):532–536. doi: 10.1097/00007890-198505000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Butler P., Israel L., Nusbacher J., Jenkins D. E., Jr, Starzl T. E. Blood transfusion in liver transplantation. Transfusion. 1985 Mar-Apr;25(2):120–123. doi: 10.1046/j.1537-2995.1985.25285169201.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clift R. A., Storb R. Histoincompatible bone marrow transplants in humans. Annu Rev Immunol. 1987;5:43–64. doi: 10.1146/annurev.iy.05.040187.000355. [DOI] [PubMed] [Google Scholar]
  6. Fabre J. W., Morris P. J. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation. 1972 Nov;14(5):608–617. doi: 10.1097/00007890-197211000-00013. [DOI] [PubMed] [Google Scholar]
  7. Fabre J. W., Morris P. J. The mechanism of specific immunosuppression of renal allograft rejection by donor strain blood. Transplantation. 1972 Nov;14(5):634–640. doi: 10.1097/00007890-197211000-00016. [DOI] [PubMed] [Google Scholar]
  8. Feduska N. J., Amend W. J., Vincenti F., Duca R., Salvatierra O. Blood transfusions before and on the day of transplantation: effects on cadaver graft survival. Transplant Proc. 1982 Jun;14(2):302–304. [PubMed] [Google Scholar]
  9. Ferguson R. M., Simmons R. L., Noreen H., Yunis E. J., Najarian J. S. Host presensitization and renal allograft success at a single institution: First transplants. Surgery. 1977 Feb;81(2):139–145. [PubMed] [Google Scholar]
  10. Fischer E., Lenhard V., Seifert P., Kluge A., Johannsen R. Blood transfusion-induced suppression of cellular immunity in man. Hum Immunol. 1980 Oct;1(3):187–194. doi: 10.1016/0198-8859(80)90013-0. [DOI] [PubMed] [Google Scholar]
  11. Groth C. G. There is no need to give blood transfusions as pretreatment for renal transplantation in the cyclosporine era. Transplant Proc. 1987 Feb;19(1 Pt 1):153–154. [PubMed] [Google Scholar]
  12. Jeannet M., Néri-Legendre C., Descoeudres C., Leski M. Does blood transfusion induce a nonspecific suppression of cell-mediated immunity? Transplant Proc. 1982 Jun;14(2):325–328. [PubMed] [Google Scholar]
  13. Kang Y., Lewis J. H., Navalgund A., Russell M. W., Bontempo F. A., Niren L. S., Starzl T. E. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology. 1987 Jun;66(6):766–773. [PMC free article] [PubMed] [Google Scholar]
  14. Kissmeyer-Nielsen F., Olsen S., Petersen V. P., Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet. 1966 Sep 24;2(7465):662–665. doi: 10.1016/s0140-6736(66)92829-7. [DOI] [PubMed] [Google Scholar]
  15. Klatzmann D., Bensussan A., Gluckman J. C., Foucault C., Dausset J., Sasportes M. Blood transfusions suppress lymphocyte reactivity in uremic patients. II. Evidence for soluble suppressor factors. Transplantation. 1983 Sep;36(3):337–340. [PubMed] [Google Scholar]
  16. Lewis J. H., Bontempo F. A., Cornell F., Kiss J. E., Larson P., Ragni M. V., Rice E. O., Spero J. A., Starzl T. E. Blood use in liver transplantation. Transfusion. 1987 May-Jun;27(3):222–225. doi: 10.1046/j.1537-2995.1987.27387235624.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Melzer J. S., Husing R. M., Feduska N. J., Tomlanovich S. J., Vincenti F., Amend W. J., Garovoy M., Salvatierra O., Jr The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipients. Transplantation. 1987 Jan;43(1):61–64. doi: 10.1097/00007890-198701000-00014. [DOI] [PubMed] [Google Scholar]
  18. Newland A. C. Idiopathic thrombocytopenic purpura and IgG: a review. J Infect. 1987 Jul;15 (Suppl 1):41–49. doi: 10.1016/s0163-4453(87)92469-8. [DOI] [PubMed] [Google Scholar]
  19. Opelz G. Improved kidney graft survival in nontransfused recipients. Transplant Proc. 1987 Feb;19(1 Pt 1):149–152. [PubMed] [Google Scholar]
  20. Opelz G., Terasaki P. I. Enhancement of kidney graft survival by blood transfusions. Transplant Proc. 1977 Mar;9(1):121–122. [PubMed] [Google Scholar]
  21. Opelz G., Terasaki P. I. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med. 1978 Oct 12;299(15):799–803. doi: 10.1056/NEJM197810122991503. [DOI] [PubMed] [Google Scholar]
  22. Opelz G., Terasaki P. I. Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet. 1974 Sep 21;2(7882):696–698. doi: 10.1016/s0140-6736(74)93268-1. [DOI] [PubMed] [Google Scholar]
  23. Opelz G., Terasaki P. I. Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet. 1974 Sep 21;2(7882):696–698. doi: 10.1016/s0140-6736(74)93268-1. [DOI] [PubMed] [Google Scholar]
  24. Opelz G., Terasaki P. I. Prolongation effect of blood transfusions on kidney graft survival. Transplantation. 1976 Oct;22(4):380–383. doi: 10.1097/00007890-197610000-00010. [DOI] [PubMed] [Google Scholar]
  25. Patel R., Terasaki P. I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969 Apr 3;280(14):735–739. doi: 10.1056/NEJM196904032801401. [DOI] [PubMed] [Google Scholar]
  26. Perloff L. J. The role of blood transfusion in the age of cyclosporine. Transplant Proc. 1986 Apr;18(2 Suppl 1):29–37. [PubMed] [Google Scholar]
  27. Persijn G. G., Cohen B., Lansbergen Q., van Rood J. J. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. Transplantation. 1979 Nov;28(5):396–401. doi: 10.1097/00007890-197911000-00010. [DOI] [PubMed] [Google Scholar]
  28. Persijn G. G., van Leeuwen A., Parlevliet J., Cohen B., Lansbergen Q., D'Amaro J., van Rood J. J. Two major factors influencing kidney graft survival in Eurotransplant: HLA-DR matching and blood transfusion(s). Transplant Proc. 1981 Mar;13(1 Pt 1):150–154. [PubMed] [Google Scholar]
  29. Rajewsky K., Takemori T. Genetics, expression, and function of idiotypes. Annu Rev Immunol. 1983;1:569–607. doi: 10.1146/annurev.iy.01.040183.003033. [DOI] [PubMed] [Google Scholar]
  30. Reitz B. A. Cardiac and cardiopulmonary transplantation. Cardiovasc Clin. 1987;17(3):347–359. [PubMed] [Google Scholar]
  31. Rodey G. E. Blood transfusions and their influence on renal allograft survival. Prog Hematol. 1986;14:99–122. [PubMed] [Google Scholar]
  32. Salvatierra O., Jr, Perkins H. A., Amend W., Jr, Feduska N. J., Duca R. M., Potter D. E., Cochrum K. C. The influence of presensitization on graft survival rate. Surgery. 1977 Feb;81(2):146–151. [PubMed] [Google Scholar]
  33. Salvatierra O., Jr, Vincenti F., Amend W., Potter D., Iwaki Y., Opelz G., Terasaki P., Duca R., Cochrum K., Hanes D. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg. 1980;192(4):543–552. doi: 10.1097/00000658-198010000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schraut W. H. Current status of small-bowel transplantation. Gastroenterology. 1988 Feb;94(2):525–538. doi: 10.1016/0016-5085(88)90449-0. [DOI] [PubMed] [Google Scholar]
  35. Scornik J. C., Ireland J. E., Howard R. J., Pfaff W. W. Assessment of the risk for broad sensitization by blood transfusions. Transplantation. 1984 Mar;37(3):249–253. doi: 10.1097/00007890-198403000-00006. [DOI] [PubMed] [Google Scholar]
  36. Singal D. P., Joseph S., Ali M., Blajchman M. A., Smith E. K., Ludwin D. Anti-idiotypic antibodies and suppressor cells in patients receiving pretransplant donor-specific blood transfusions. Transplant Proc. 1987 Aug;19(4):3399–3401. [PubMed] [Google Scholar]
  37. Singal D. P., Joseph S. Role of blood transfusions on the induction of antibodies against recognition sites on T lymphocytes in renal transplant patients. Hum Immunol. 1982 Apr;4(2):93–108. doi: 10.1016/0198-8859(82)90010-6. [DOI] [PubMed] [Google Scholar]
  38. Slater A. D., Klein J. B., Gray L. A., Jr Clinical orthotopic cardiac transplantation. Am J Surg. 1987 Jun;153(6):582–593. doi: 10.1016/0002-9610(87)90167-x. [DOI] [PubMed] [Google Scholar]
  39. Soulillou J. P., Blandin F., Günther E., Lemoine V. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation. 1984 Jul;38(1):63–67. doi: 10.1097/00007890-198407000-00015. [DOI] [PubMed] [Google Scholar]
  40. Squifflet J. P., Sutherland D. E., Florack G., Moudry K., Alexandre G. P. Current status of pancreas transplantation. Adv Nephrol Necker Hosp. 1988;17:343–362. [PubMed] [Google Scholar]
  41. Stiller C. R., Lockwood B. L., Sinclair N. R., Ulan R. A., Sheppard R. R., Sharpe J. A., Hayman P. Beneficial effect of operation-day blood-transfusions on human renal-allograft survival. Lancet. 1978 Jan 28;1(8057):169–170. doi: 10.1016/s0140-6736(78)90608-6. [DOI] [PubMed] [Google Scholar]
  42. Terasaki P. I., Kreisler M., Mickey R. M. Presensitization and kidney transplant failures. Postgrad Med J. 1971 Feb;47(544):89–100. [PMC free article] [PubMed] [Google Scholar]
  43. Terasaki P. I., Opelz G., Mickey M. R. Analysis of yearly kidney transplant survival rates. Transplant Proc. 1976 Jun;8(2):139–144. [PubMed] [Google Scholar]
  44. Terasaki P. I. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation. 1984 Feb;37(2):119–125. doi: 10.1097/00007890-198402000-00001. [DOI] [PubMed] [Google Scholar]
  45. Werner-Favre C., Jeannet M., Harder F., Montandon A. Blood transfusions, cytotoxic antibodies, and kidney graft survival. Preliminary results of a systematic transfusion protocol. Transplantation. 1979 Oct;28(4):343–346. doi: 10.1097/00007890-197910000-00016. [DOI] [PubMed] [Google Scholar]
  46. Williams G. M., Hume D. M., Hudson R. P., Jr, Morris P. J., Kano K., Milgrom F. "Hyperacute" renal-homograft rejection in man. N Engl J Med. 1968 Sep 19;279(12):611–618. doi: 10.1056/NEJM196809192791201. [DOI] [PubMed] [Google Scholar]
  47. van Es A. A., Balner H. Effect of pretransplant transfusions on kidney allograft survival. Transplant Proc. 1979 Mar;11(1):127–137. [PubMed] [Google Scholar]
  48. van Hooff J. P., van der Steen G. J., Schippers H. M., van Rood J. J. Efficacy of HL-A matching in Eurotransplant. Lancet. 1972 Dec 30;2(7792):1385–1388. doi: 10.1016/s0140-6736(72)92962-5. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES